Use of exploratory factor analysis to ascertain the correlation between the activities of rheumatoid arthritis and infection by human parvovirus B19

Medicina (Lithuania)

Volumn 51, Issue 1, 2015, Pages 18-24

  Kakurina, Natalja ^a   Kadisa, Anda ^b   Lejnieks, Aivars ^b   Mikazane, Helena ^b   Kozireva, Svetlana ^b   Murovska, Modra ^b  

^a Daugavpils Regional Hospital   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

Author keywords

Exploratory factor analysis; Human parvovirus B19; Rheumatoid arthritis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGED; BLOOD; COMPLICATION; EVALUATION STUDY; FACTOR ANALYSIS; FEMALE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOLOGY; MALE; MIDDLE AGED; PARVOVIRUS INFECTION; RHEUMATOID ARTHRITIS; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ARTHRITIS, RHEUMATOID; DNA, VIRAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; YOUNG ADULT;

EID: 84951977658     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medici.2015.01.004     Document Type: Article

References (27)

1. Kvien T.K., Scherer H.U., Burmester G.-R. Rheumatoid arthritis: pathogenesis, clinical aspects and diagnosis. Eular Online Course on Rheumatic Diseases [serial online] 2008, module N5. Available from: www.eular-onlinecourse.org.
2. Kerr J.R. Pathogenesis of human parvovirus B19 in rheumatic diseases. Ann Rheum Dis 2000, 59:672-683.
3. Firestein G.S., Budd R.C., Harris E.D., Genovese M.C., Sargent J.S., Sledge C.B., et al. Kelley's textbook of rheumatology 2008, W.B. Saunders Company. 8th ed.
4. Broliden K., Tolfvenstam T., Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med 2006, 4:285-304.
5. Bratslavska O., Rumba I. Human parvovirus B19 and the spectrum of diseases caused by this virus. Proc Latv Acad Sci 2005, 59:108-122.
6. Chen Y.S., Chou P.H., Li S.N., Tsai W.C., Lin K.H., Tsai K.B., et al. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2006, 33:887-891.
7. Colmegne I., Alberts-Grill N. Parvovirus B19: its role in chronic arthritis. Rheum Dis Clin North Am 2009, 35:95-110.
8. Takahashi Y., Murai C., Shibata S., Munakata Y., Ishii T., Ishii K., et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998, 95:8227-8232.
9. Lu J., Zhi N., Wong S., Brown K.E. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 2001, 193:582-590.
10. Kozireva S.V., Zestkova J.V., Mikazane H.J., Kadisa A.L., Kakurina N.A., Lejnieks A.A., et al. Incidence and clinical significance of parvovirus b19 infection in patients with rheumatoid arthritis. J Rheumatol 2008, 35:1265-1270.
11. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48.
12. van Gestel A.M., Prevoo M.L., van't Hof M.A., van Rijswijk M.H., van de Putte L.B., van Riel P.L. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League against Rheumatism Criteria. Arthritis Rheum 1996, 39:34-40.
13. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
14. McPherson R.A., Pincus M.R. Henrys clinical diagnosis and management by laboratory methods 2006, W.B. Saunders Company. 21st ed.
15. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996, 39:713-722.
16. The art of information processing. Statistical data analysis and recovery of hidden regularities [Translation from German]. 2005.
17. Pett M.A., Lackey N.R., Sullivan J.J. Making sense of factor analysis: the use of factor analysis for instrument development in health care research 2003, Sage Publications, Thousand Oaks, CA.
18. Katz M.H. Multivariable analysis - a practical guide for clinicians 2006, University of California, San Francisco. 2nd ed.
19. Lunardi C., Tiso M., Borgato L., Nanni L., Millo R., De Sandre G., et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998, 28:936-948.
20. Colmegna I., Alberts-Grill N. Parvovirus B19: its role in chronic arthritis. Rheum Dis Clin N Am 2009, 35:95-110.
21. Barzilai O., Ram M., Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol 2007, 19:636-643.
22. Murai C., Munakata Y., Takahashi Y., Ishii T., Shibata S., Muryoi T., et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 1999, 58:130-132.
23. Ray N.B., Nieva D.R.C., Seftor E.A., Hendrix M.J.C. Cartilage matrix invasion studies with primary human synovial cells and human parvovirus B19. Arthritis Rheum 1999, 42:S339.
24. Ferri C., Zakrzewska K., Longombardo G., Giuggioli D., Storino F.A.A., Pasero G., et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999, 17:718-720.
25. Lewkonia R.M., Horne D., Dawood M.R. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995, 21:430-432.
26. Lehmann H. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence. J Clin Virol 2002, 25:135-143.
27. Lehmann H.W., Plentz A., Von Landenberg P., Müller-Godeffroy E., Modrow S. Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies. Arthritis Res Ther 2004, 6:R1-R6.